Home | Welcome to Contract Pharma   
Last Updated Sunday, September 21 2014
Print

Risk Evaluation and Mitigation Strategy (REMS)



A strategy to manage a known or potential serious risk associated with a drug or biological product.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On